Credit Suisse’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.7M | Buy |
66,776
+16,448
| +33% | +$420K | ﹤0.01% | 1960 |
|
|
2023
Q4 | $455K | Sell |
50,328
-5,795
| -10% | -$52.4K | ﹤0.01% | 2766 |
|
|
2023
Q3 | $358K | Sell |
56,123
-24,866
| -31% | -$159K | ﹤0.01% | 2854 |
|
|
2023
Q2 | $898K | Buy |
80,989
+32,807
| +68% | +$364K | ﹤0.01% | 2438 |
|
|
2023
Q1 | $740K | Buy |
48,182
+5,193
| +12% | +$79.7K | ﹤0.01% | 2493 |
|
|
2022
Q4 | $954K | Buy |
42,989
+12,555
| +41% | +$279K | ﹤0.01% | 2358 |
|
|
2022
Q3 | $497K | Buy |
30,434
+5,647
| +23% | +$92.2K | ﹤0.01% | 2761 |
|
|
2022
Q2 | $360K | Sell |
24,787
-1,868
| -7% | -$27.1K | ﹤0.01% | 3035 |
|
|
2022
Q1 | $492K | Buy |
26,655
+36
| +0.1% | +$664 | ﹤0.01% | 2965 |
|
|
2021
Q4 | $633K | Buy |
26,619
+3,361
| +14% | +$79.9K | ﹤0.01% | 2876 |
|
|
2021
Q3 | $572K | Buy |
+23,258
| New | +$572K | ﹤0.01% | 2917 |
|
|
2021
Q2 | – | Sell |
-10,784
| Closed | -$235K | – | 3642 |
|
|
2021
Q1 | $235K | Sell |
10,784
-14,396
| -57% | -$314K | ﹤0.01% | 3232 |
|
|
2020
Q4 | $642K | Buy |
+25,180
| New | +$642K | ﹤0.01% | 2845 |
|